An investigation of the relationship between clinical features of amoebiasis and Entamoeba histolytica genotypes

dc.contributor.authorAraz, Remzi Engin
dc.contributor.authorKoru, Ozgur
dc.contributor.authorTanyuksel, Mehmet
dc.contributor.authorOzekinci, Tuncer
dc.contributor.authorCeylan, Ali
dc.contributor.authorGuclu Kilbas, Hatice Zeynep
dc.contributor.authorCicek, Mutalip
dc.date.accessioned2024-04-24T17:21:08Z
dc.date.available2024-04-24T17:21:08Z
dc.date.issued2012
dc.departmentDicle Üniversitesien_US
dc.description.abstractAim: To determine the presence of Entamoeba histolytica/E. dispar and E. moshkovskii in stool samples, tRNA-based short tandem repeat gene polymorphism in E. histolytica isolates, and the relationship between amoeba load and clinical outcome in studies. Materials and methods: This study involved 840 stools samples of individuals having diarrhea/dysentery and individuals who were asymptomatic by using microscopy, culture, E. histolytica antigen ELISA, and conventional/real-time PCR methods. Results: Of the 840 samples analyzed, 4.3% (36/840), 2.6% (22/840), and 7.4% (62/840) of the stool samples were determined to be positive by E. histolytica antigen ELISA, and real-time PCR for E. histolytica and E. dispar, respectively. Thirty-five of the 62 (56.4%) samples positive for E. dispar and 20 of the 22 (91.0%) samples positive for E. histolytica were from dysenteric individuals as revealed by real-time PCR. Although there was no statistically significant difference in patients with diarrhea, a correlation might be seen between amoeba load and clinical outcome in those infected with E. histolytica, since amoeba load was usually determined 103 copies/mL or higher in patients with diarrhea. In this study, 3 different genotypes were defined in 16 isolates by using 6 loci (A-L, N-K2, D-A, R-R, S-D, and S-TGA-Q). Conclusion: Our results demonstrated that real-time PCR is a useful, reliable, and sensitive method for the determination of E. histolytica in stools and for differentiation from E. dispar. It is suggested that parasite load might affect clinical outcome.en_US
dc.description.sponsorshipTUBITAKen_US
dc.description.sponsorshipThis study was supported by a grant from TUBITAK and was presented as a poster at the 60th ASTMH meeting, 4-8 December 2011, in Philadelphia, USA.en_US
dc.identifier.doi10.3906/sag-1112-23
dc.identifier.endpage1156en_US
dc.identifier.issn1300-0144
dc.identifier.issn1303-6165
dc.identifier.scopus2-s2.0-84871233488
dc.identifier.scopusqualityQ1
dc.identifier.startpage1147en_US
dc.identifier.urihttps://doi.org/10.3906/sag-1112-23
dc.identifier.urihttps://hdl.handle.net/11468/19378
dc.identifier.volume42en_US
dc.identifier.wosWOS:000312424300001
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoenen_US
dc.publisherTubitak Scientific & Technological Research Council Turkeyen_US
dc.relation.ispartofTurkish Journal of Medical Sciences
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectEntamoeba Histolyticaen_US
dc.subjectAmoebiasisen_US
dc.subjectReal-Time Pcren_US
dc.subjectTrna Geneen_US
dc.subjectGenotypingen_US
dc.titleAn investigation of the relationship between clinical features of amoebiasis and Entamoeba histolytica genotypesen_US
dc.titleAn investigation of the relationship between clinical features of amoebiasis and Entamoeba histolytica genotypes
dc.typeArticleen_US

Dosyalar